Late-Stage Studies of a Cancer-Drug Combination Fall Short in NSCLC Patients NewsbyAdministratorSeptember 22, 20231 minute readNo comments
Major Injury Blow for Dallas Cowboys Defense NewsbyAdministratorSeptember 22, 20232 minute readNo comments
U.S. Stock Futures Rebound After Fed’s Interest-Rate Forecast NewsbyAdministratorSeptember 22, 20232 minute readNo comments
News BioLineRx Shares Jump on FDA Approval BioLineRx, a biopharmaceutical company, saw its shares surge by 22% to $2.54 in premarket trading following the approval… byAdministratorSeptember 11, 2023No comments
